Literature DB >> 18573670

Abnormal myelination in Angelman syndrome.

Inga Harting1, Angelika Seitz, Dietz Rating, Klaus Sartor, Johannes Zschocke, Bart Janssen, Friedrich Ebinger, Nicole I Wolf.   

Abstract

Patients with Angelman syndrome (OMIM # 105830) are generally thought to have normal brain imaging studies except for occasional minor cerebral atrophy. We report 9 patients with genetically proven Angelman syndrome, who were examined by magnetic resonance imaging (MRI) between the ages of 7.5 months and 5 years. MRI in the 5 patients examined during infancy revealed myelination delay and a deficit of white matter. Retarded and/or abnormal myelination in Angelman syndrome seems to be a common finding that may be diagnostically misleading. This is particularly important in the evaluation of infants with possible Angelman syndrome, who present with nonspecific clinical features and have not yet developed the characteristic behavioural, language, and movement abnormalities.

Entities:  

Mesh:

Year:  2008        PMID: 18573670     DOI: 10.1016/j.ejpn.2008.04.005

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  25 in total

1.  Relationship between aberrant brain connectivity and clinical features in Angelman Syndrome: a new method using tract based spatial statistics of DTI color-coded orientation maps.

Authors:  Vijay N Tiwari; Jeong-won Jeong; Benjamin J Wilson; Michael E Behen; Harry T Chugani; Senthil K Sundaram
Journal:  Neuroimage       Date:  2011-07-30       Impact factor: 6.556

2.  Do the physiotherapy results make us happy in a case with 'happy puppet' (Angelman) syndrome?

Authors:  Ozgun Kaya Kara; Akmer Mutlu; Mintaze Kerem Gunel; Goknur Haliloglu
Journal:  BMJ Case Rep       Date:  2010-12-29

3.  Decreased Axon Caliber Underlies Loss of Fiber Tract Integrity, Disproportional Reductions in White Matter Volume, and Microcephaly in Angelman Syndrome Model Mice.

Authors:  Matthew C Judson; Alain C Burette; Courtney L Thaxton; Alaine L Pribisko; Mark D Shen; Ashley M Rumple; Wilmer A Del Cid; Beatriz Paniagua; Martin Styner; Richard J Weinberg; Benjamin D Philpot
Journal:  J Neurosci       Date:  2017-06-29       Impact factor: 6.167

4.  Abnormal language pathway in children with Angelman syndrome.

Authors:  Benjamin J Wilson; Senthil K Sundaram; A H M Huq; Jeong-Won Jeong; Stacey R Halverson; Michael E Behen; Duy Q Bui; Harry T Chugani
Journal:  Pediatr Neurol       Date:  2011-05       Impact factor: 3.372

5.  Alterations in white matter pathways in Angelman syndrome.

Authors:  Sarika U Peters; Walter E Kaufmann; Carlos A Bacino; Adam W Anderson; Pavani Adapa; Zili Chu; Ragini Yallampalli; Elfrides Traipe; Jill V Hunter; Elisabeth A Wilde
Journal:  Dev Med Child Neurol       Date:  2010-12-01       Impact factor: 5.449

6.  Disrupted Functional and Structural Connectivity in Angelman Syndrome.

Authors:  H M Yoon; Y Jo; W H Shim; J S Lee; T S Ko; J H Koo; M S Yum
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-07       Impact factor: 3.825

7.  Allelic specificity of Ube3a expression in the mouse brain during postnatal development.

Authors:  Matthew C Judson; Jason O Sosa-Pagan; Wilmer A Del Cid; Ji Eun Han; Benjamin D Philpot
Journal:  J Comp Neurol       Date:  2014-06-01       Impact factor: 3.215

8.  The Angelman syndrome protein Ube3a/E6AP is required for Golgi acidification and surface protein sialylation.

Authors:  Kathryn H Condon; Jianghai Ho; Camenzind G Robinson; Cyril Hanus; Michael D Ehlers
Journal:  J Neurosci       Date:  2013-02-27       Impact factor: 6.167

9.  Genetic heterogeneity in 26 infants with a hypomyelinating leukodystrophy.

Authors:  Natsuko Arai-Ichinoi; Mitsugu Uematsu; Ryo Sato; Tasuku Suzuki; Hiroki Kudo; Atsuo Kikuchi; Naomi Hino-Fukuyo; Mitsuyo Matsumoto; Kazuhiko Igarashi; Kazuhiro Haginoya; Shigeo Kure
Journal:  Hum Genet       Date:  2015-11-23       Impact factor: 4.132

Review 10.  Angelman syndrome - insights into a rare neurogenetic disorder.

Authors:  Karin Buiting; Charles Williams; Bernhard Horsthemke
Journal:  Nat Rev Neurol       Date:  2016-09-12       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.